Toronto, Canada (PRWEB) September 05, 2013
Deciem, the beauty brand umbrella behind Inhibitif, Fountain, Avestan, LHN and other brands, announced today that it has appointed Michael Basler as Group CFO to oversee the financial and business operations of certain managed brands.
Michael Basler joins Roy Vandal, current CFO of Deciem, as the umbrella launches its second 2013 brand, Fountain, in the UK.
"We are growing ambitiously. And ambition attracts ambition. I cannot think of a better person for this role," said Brandon Truaxe, Founder and CEO of Deciem and all Deciem-managed brands.
About Michael Basler:
For more than 20 years, Michael has held senior operational and financial management positions of increasing responsibility with privately-held and publicly-listed companies. He has held the position of Chief Financial Officer in various start-up and early-stage growth enterprises within the technology sector and has experience in establishing and operationally staffing international subsidiary organizations. Michael was also instrumental in various early stage funding arrangements, M&A activities and in preparing a number of the companies he served with for their initial public offerings. Michael was designated as a Certified Management Accountant in 1992 and holds an Honours degree in Economics with minors in Finance and Accounting from Wilfrid Laurier University.
For information about Deciem, visit http://www.deciem.com.